Korea Lidocaine Hydrochloride 1% Injection
Lidocaine Hydrochloride Hydrate 10.665mg
Solution · Prescription medication
Daehan Pharmaceutical Co., Ltd.
MFDS item code 199500290 · Notified 1995.03.22 · Insurance code 645100751
Anesthesia (epidural, nerve block, infiltration, etc.); treatment of ventricular arrhythmias
This drug is primarily used for various methods of anesthesia such as epidural anesthesia, nerve block anesthesia, infiltration anesthesia, and surface anesthesia. It is also utilized in the treatment of cardiac rhythm disorders such as ventricular arrhythmias. It is effective in treating multiple anesthetic and heart-related conditions.
[Anesthesia] ㆍAdults 1. Epidural anesthesia (reference maximum dose: 200㎎ of lidocaine hydrochloride per dose): 100-200㎎ 2. Conduction anesthesia (reference maximum dose: 200㎎ of lidocaine hydrochloride per dose): 30-200㎎; 30-100㎎ for supportive nerve block, up to 50㎎ for intercostal nerve block 3. Infiltration anesthesia (reference maximum dose: 200㎎ of lidocaine hydrochloride per dose): 20-200㎎ 4. Topical anesthesia: Apply or spray an appropriate amount ㆍAdjust the dose as appropriate according to age, area and site of anesthesia, tissue, symptoms, constitution, and general condition. [Medical use] ㆍAdults 1. Single intravenous dose: Slowly inject 50-100㎎ (1-2㎎/㎏) of lidocaine hydrochloride intravenously over 1-2 minutes. If no effect is observed, administer the same dose after 5 minutes. To maintain the effect, the same dose may also be given at intervals of 10-20 minutes; however, the reference maximum dose within 1 hour is 300㎎. 2. Intravenous infusion: If a single intravenous dose is effective and maintenance of the effect is desired, administer by intravenous infusion under continuous electrocardiographic monitoring. Inject lidocaine hydrochloride intravenously at a rate of 1-2㎎ per minute. The infusion rate may be increased if necessary, but the maximum rate is 4㎎ per minute.
This drug should not be used in patients with intoxication, bleeding, or shock status during epidural anesthesia. It is also safer not to administer it to patients with inflammation at the injection site or nearby, or to patients with sepsis. Patients with allergies to this drug or similar amide local anesthetics should avoid its use. It should be used cautiously in patients with central nervous system diseases, pregnant women, the elderly, patients with severe hypertension, and those with spinal deformities. During administration, symptoms of shock such as hypotension, facial pallor, abnormal pulse rate, and respiratory depression may occur, so careful observation is necessary. Rarely, malignant hyperthermia symptoms such as rapid temperature rise and muscle rigidity may occur; if such symptoms appear, administration must be stopped immediately and specialized treatment is required. Signs of toxicity, such as tremors or convulsions, may appear; if these symptoms occur, administration should be stopped immediately and appropriate treatment pursued. Symptoms such as drowsiness, anxiety, dizziness, and nausea may also arise, so be attentive to these changes. Hypersensitivity reactions such as skin rash or swelling may occur; if any abnormal symptoms arise, immediate notification is necessary. It is important to prepare for immediate emergency treatment when using this drug. During administration, the lowest concentration and minimum dosage possible should be used, and it must be confirmed that the injection needle has not entered a blood vessel. Careful attention should be taken when using this drug in combination with vasoconstrictors as side effects may occur in certain patient populations. Its safety in pregnant women has not been established, so administration should be considered only after thoroughly weighing the necessity and risks involved. The elderly may be more sensitive to this drug and vasoconstrictors; therefore, dosage adjustment and condition monitoring may be necessary. It is preferable not to use this drug for ophthalmic purposes. Long-term high-dose administration should be avoided, as the metabolites of this drug may have mutagenic potential. In clinical use, it should not be administered to patients with severe cardiac conduction disturbances or those allergic to this drug. Caution should be exercised in patients with poor cardiac function, severely impaired liver or kidney function, those in shock, and the elderly. In cases of overdose, there is a risk of cardiac arrhythmias, hypotension, and cardiac arrest; therefore, continuous ECG and blood pressure monitoring are necessary during administration. There may be interactions with other medications, so consultation with healthcare professionals is essential. This drug is primarily metabolized in the liver, so special caution should be taken when administering it to elderly patients with impaired liver function.
shock
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a sealed container to prevent exposure to air, and it is recommended to keep it at a temperature between 1°C and 30°C at room temperature. This storage practice can help maintain the drug's effectiveness and prevent degradation.
A colorless and transparent solution filled in a colorless transparent vial.
10 vials/box [(20 mL/vial)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Lidocaine Hydrochloride Hydrate 10.665mg
Solution · Prescription medication
Daehan Pharmaceutical Co., Ltd.
Lidocaine Hydrochloride Hydrate 21.33mg
Prescription medication
Cheil Pharmaceutical Co., Ltd.
Lidocaine Hydrochloride Hydrate 21.33mg
Injections · Prescription medication
Huons Co., Ltd.
Lidocaine Hydrochloride Hydrate 21.33mg
Solution · Prescription medication
Daehan Pharmaceutical Co., Ltd.
Lidocaine Hydrochloride Hydrate 42.66mg
Solution · Prescription medication
Daehan Pharmaceutical Co., Ltd.
Lidocaine Hydrochloride Hydrate 2.13g
Prescription medication
Taekjun Pharmaceutical Co., Ltd.
Lidocaine Hydrochloride Hydrate 2g
Prescription medication
Aliko Pharmaceutical Co., Ltd.
Lidocaine Hydrochloride Hydrate 10.67mg
Injections · Prescription medication
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.